https://www.statnews.com/2020/01/12/venture-capitalist-alexis-borisy-bring-down-drug-prices/ … Does anybody understand why this business model hasn't been done before? (Develop new drugs that mimic the effects of other approved drugs; sell them at lower prices; make a profit by gaining market share.)
-
Show this thread
-
"But at least one big factor in this plan is not entirely in EQRx’s control: Someone has to buy the equivalar instead of the blockbuster it copied precisely because it is cheaper. Faith that this will happen is one of the reasons investors are backing Borisy." Hmmm...
1 reply 0 retweets 2 likesShow this thread -
Why isn't it obvious that insurance companies would prefer to cover a (FDA-approved, proven-equivalent) cheap drug over an expensive drug for the same disease? Even monopolies and oligopolies have an interest in lowering their *costs*.
4 replies 0 retweets 3 likesShow this thread
They need doctors to prescribe the new drug or pharmacists to be allowed to make a substitution on the patient's behalf. The former is an incredible marketing challenge, the latter a regulatory one.
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.